文献速递眼底病与葡萄膜炎

长链非编码RNA NEAT1/miR-320a/HIF-1α竞争性内源RNA调控网络在糖尿病视网膜病变中的调控作用

Regulation of Long Noncoding RNA NEAT1/miR-320a/HIF-1α Competitive Endogenous RNA Regulatory Network in Diabetic Retinopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2023-01-01

该研究在ARPE-19细胞中探究lncNEAT1/miR-320a竞争性内源RNA网络调控HIF-1α的机制及其在糖尿病视网膜病变中的潜在作用。高糖处理促进ARPE-19细胞迁移、侵袭和通透性;沉默lncNEAT1可下调HIF-1α、N-钙黏蛋白和波形蛋白,上调ZO-1和闭合蛋白,抑制高糖诱导的细胞迁移、通透性和侵袭。双荧光素酶报告实验和RIP实验证实miR-320a与lncNEAT1及HIF-1α结合;在糖尿病大鼠模型中,沉默lncNEAT1抑制HIF-1α/ANGPTL4/p-STAT3通路激活并减轻视网膜病变。结论认为该ceRNA网络激活ANGPTL4/p-STAT3通路并促进高糖诱导的ARPE-19细胞侵袭和迁移。

要点

  • 高糖处理促进ARPE-19细胞迁移、侵袭和通透性。
  • 沉默lncNEAT1可抑制高糖诱导的ARPE-19细胞迁移、通透性和侵袭。
  • 糖尿病大鼠模型中沉默lncNEAT1抑制HIF-1α/ANGPTL4/p-STAT3通路并减轻视网膜病变。

核心结论

  • lncNEAT1/miR-320a/HIF-1α ceRNA网络激活ANGPTL4/p-STAT3通路并促进高糖诱导的ARPE-19细胞侵袭和迁移。

研究设计与样本

  • 体外研究:ARPE-19细胞培养于正常或高糖培养基,采用划痕、Transwell和FITC-葡聚糖染色实验检测细胞迁移、侵袭和通透性。
  • 采用双荧光素酶报告实验验证lncNEAT1与miR-320a结合,采用RIP实验验证miR-320a与HIF-1α结合。
  • 用lncNEAT1或HIF-1α shRNA或miR-320a agomir处理ARPE-19细胞以确定ANGPTL4/p-STAT3通路激活。
  • 在糖尿病视网膜病变大鼠模型中确定lncNEAT1在DR中的作用及其对miR-320a和HIF-1α的调控。

主要发现

  • 高糖处理促进ARPE-19细胞迁移、侵袭和通透性。
  • 沉默lncNEAT1后HIF-1α、N-钙黏蛋白和波形蛋白水平下调,ZO-1和闭合蛋白水平上调,高糖处理ARPE-19细胞的迁移、通透性和侵袭受抑制。
  • HIF-1α过表达增加N-钙黏蛋白和波形蛋白表达,降低ZO-1和闭合蛋白表达,并促进ARPE-19细胞迁移、通透性和侵袭。
  • 预测并证实miR-320a与lncNEAT1及HIF-1α结合。
  • 糖尿病大鼠模型中沉默lncNEAT1抑制HIF-1α/ANGPTL4/p-STAT3通路激活并减轻视网膜病变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the mechanism that long noncoding RNA NEAT1 (lncNEAT1)/miR-320a competitive endogenous RNA (ceRNA) network regulates hypoxia-inducible factor-1α (HIF-1α) in ARPE-19 cells and its potential role in diabetic retinopathy (DR). METHODS: ARPE-19 cells were cultured in a normal or high-glucose (HG) medium, and cell migration, invasion, and permeability were detected by scratch, transwell, and FITC-dextran staining assays. LncNEAT1, HIF-1α, ZO-1, occludin, N-cadherin, and vimentin levels were tested. The binding of lncNEAT1 to miR-320a was verified by dual-luciferase reporter assay, and the binding of miR-320a to HIF-1α by RIP assay. ARPE-19 cells were treated with lncNEAT1 or HIF-1α shRNA or miR-320a agomir to determine the activation of ANGPTL4/p-STAT3 pathway. The effect of lncNEAT1 in DR and its regulations on miR-320a and HIF-1α were determined in a rat model of DR. RESULTS: HG treatment promoted the migration, invasion, and permeability of ARPE-19 cells. After lncNEAT1 silencing, HIF-1α, N-cadherin, and vimentin levels were downregulated, ZO-1 and occludin levels were upregulated, and the migration, permeability, and invasion of HG-treated ARPE-19 cells were inhibited. However, HIF-1α overexpression increased N-cadherin and vimentin expression, reduced ZO-1 and occludin expression, and promoted the migration, permeability, and invasion of ARPE-19 cells. The binding of miR-320a with both lncNEAT1 and HIF-1α was predicted and confirmed. In a diabetic rat model, silencing lncNEAT1 inhibited HIF-1α/ANGPTL4/p-STAT3 pathway activation and alleviated retinopathy. CONCLUSIONS: The lncNETA1/miR-320a/HIF-1α ceRNA network activates the ANGPTL4/p-STAT3 pathway and promotes HG-induced ARPE-19 cell invasion and migration.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zhu X, Wang Y, Cheng L, et al. Regulation of Long Noncoding RNA NEAT1/miR-320a/HIF-1α Competitive Endogenous RNA Regulatory Network in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2023. PMID: 37432846. doi:10.1167/iovs.64.10.11

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。